This post-doctoral training grant application is a vital component of the Committee on Clinical Pharmacology and Pharmacogenomics, providing a mechanism for the training of young clinical investigators in preparation for an independent research career in Clinical Pharmacology. The Committee on Clinical Pharmacology and Pharmacogenomics is an interdepartmental unit comprised of faculty in the Departments of Anesthesia and Critical Care, Human Genetics, Medicine, Pediatrics, and Psychiatry, who have a shared interest and background in the principles of clinical pharmacology and pharmacogenomics. The training program also includes other faculty within the Biological Sciences Division who are involved in some aspect of clinical pharmacology and pharmacogenomics. The faculty jointly provide a core of knowledge regarding basic principles: pharmacodynamics and pharmacokinetics, drug disposition and metabolism, drug interactions, and various assay methodologies. Mark J. Ratain, M.D., who is Chairman of the Committee, directs the program along with Michael Maitland, M.D., Ph.D. who was appointed as the Associate Director of Fellow Education. An Executive Committee comprised of three other faculty representing the Committee's membership will advise them. Funding is requested to support the full-time research activities of 5 post- doctoral trainees each year. The majority of these trainees will have medical degrees and be board eligible in their area of specialty. A small number of trainees will hold Ph.D and/or Pharm.D. degrees The program will concentrate on research training that will take place under the supervision of the trainee's preceptor. Each trainee will be expected to enhance his/her education with formal coursework and participation in seminars, journal clubs and directed readings. The trainee will participate in activities such as the Clinical Pharmacology Consult Service, the Institutional Review Board, and the Pharmacy and Therapeutics Committee. A maximum of 10% effort (e.g. one-half day per week) will be allowed for clinical responsibilities in the area of the trainee's specialty. Upon completion of this program, the trainee is expected to become accomplished in basic research methodology, experimental design, and data interpretation and presentation, and be prepared for a competitive academic research career, as well as certification in Clinical Pharmacology.
The training program in Clinical Pharmacology and Pharmacogenomics at the University of Chicago provides the intellectual environment, formal instruction, peer interaction and clinical experience necessary for trainees to acquire knowledge, skills, and attitudes essential to the practice of clinical pharmacology.
|Applebaum, Mark A; Henderson, Tara O; Lee, Sang Mee et al. (2015) Second malignancies in patients with neuroblastoma: the effects of risk-based therapy. Pediatr Blood Cancer 62:128-33|
|Maitland, Michael L; Levine, Matthew R; Lacouture, Mario E et al. (2014) Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer. BMC Cancer 14:5|
|Maranville, Joseph C; Nanda, Rita; Fleming, Gini F et al. (2014) Gene expression of peripheral blood cells reveals pathways downstream of glucocorticoid receptor antagonism and nab-paclitaxel treatment. Pharmacogenet Genomics 24:451-8|
|Muller, Peter; Quintana, Fernando A; Rosner, Gary L et al. (2014) Bayesian inference for longitudinal data with non-parametric treatment effects. Biostatistics 15:341-52|
|Eadon, Michael T; Jacob, Alexander; Cunningham, Patrick N et al. (2014) Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells. Immunology 143:363-73|
|Applebaum, Mark A; Thomas, Dafydd G; Hembrough, Todd et al. (2014) Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma. Appl Immunohistochem Mol Morphol 22:593-9|
|Applebaum, Mark A; Skol, Andrew D; Bond, Elisabeth E et al. (2014) Radiation-induced apoptosis varies among individuals and is modified by sex and age. Int J Radiat Biol 90:903-8|
|Fang, H; Liu, X; Ramírez, J et al. (2014) Establishment of CYP2D6 reference samples by multiple validated genotyping platforms. Pharmacogenomics J 14:564-72|
|Eadon, Michael T; Hack, Bradley K; Alexander, Jessy J et al. (2013) Cell cycle arrest in a model of colistin nephrotoxicity. Physiol Genomics 45:877-88|
|Gamazon, Eric R; Lamba, Jatinder K; Pounds, Stanley et al. (2013) Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients. Blood 121:4366-76|
Showing the most recent 10 out of 52 publications